Outcomes of GnRH Agonist and GnRH Antagonist Regimens for IVF in Women Aged up to 40.

dc.contributor.authorJordão, Érika Vieira de Souza
dc.contributor.authorNakagawa, Hitomi Miura
dc.contributor.authorEstrela, Flavielly Souza
dc.contributor.authorMorais, Raiene Barbosa de
dc.contributor.authorGomes-Sobrinho, David Barreira
dc.contributor.authorCarvalho, Bruno Ramalho de
dc.date.accessioned2016-10-04T07:18:49Z
dc.date.available2016-10-04T07:18:49Z
dc.date.issued2016-01
dc.description.abstractObjective: To compare outcomes among good-prognosis patients undergoing in vitro fertilization and intracytoplasmic sperm injection followed by embryo transfer (IVF/ ICSI-ET) in GnRH-agonist (GnRH-a) and GnRH-antagonist (GnRH-ant) regimens. Methods: Retrospective analysis of 434 IVF/ICSI-ET cycles performed in a private center, in women aged up to 40: GnRH-a (n = 291) and GnRH-ant (n = 143). Pregestational, gestational and perinatal outcomes were evaluated. Statistical analysis was performed by unpaired t-test, Mann-Whitney test and Fisher’s exact test. Significance was set at p < 0.05. Results: GnRH-a regimen was associated with higher amounts of total oocytes (10.7 ± 5.7 vs 9.3 ± 5.7, p < 0.001), mature oocytes (8.2 ± 4,5 vs 6.8 ± 4.4, p < 0.001) and good quality embryos transferred (1.7 ± 0.8 vs 1.5 ± 0.9; p < 0.05). Rates of fertilization, embryo implantation and live births were also higher in GnRH-a (72.8%, 27.6% and 48.8%, respectively) compared to GnRH-ant (65.3%, 14.7% and 26.6%, respectively; p < 0.0001). There were no significant differences between rates of preterm delivery or low birth weight, comparing the two groups. Conclusion: Our results suggest that the long GnRH-a regimen is the one that offers the best reproductive outcomes among in women aged up to 40 undergoing IVF/ICSI-ET.en_US
dc.identifier.citationJordão Érika Vieira de Souza, Nakagawa Hitomi Miura, Estrela Flavielly Souza, Morais Raiene Barbosa de, Gomes-Sobrinho David Barreira, Carvalho Bruno Ramalho de. Outcomes of GnRH Agonist and GnRH Antagonist Regimens for IVF in Women Aged up to 40. Acta Medica International. 2016 Jan-June; 3(1): 46-49.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/177570
dc.language.isoenen_US
dc.source.urihttps://www.actamedicainternational.com/article/28en_US
dc.subjectGnRH agonisten_US
dc.subjectGnRH antagonisten_US
dc.subjectIVFen_US
dc.subjectICSIen_US
dc.subjectReproductive outcomesen_US
dc.titleOutcomes of GnRH Agonist and GnRH Antagonist Regimens for IVF in Women Aged up to 40.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ami2016v3n1p46.pdf
Size:
496.63 KB
Format:
Adobe Portable Document Format
Description:
Original article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: